Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

3,255

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

3,255 results for “Pancreatic cancer”

Learn how ShareScore rates datasets ↗
ClinicalTrials.gov36/100

Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer

ClinicalTrials.gov study NCT01273805. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer

ClinicalTrials.gov study NCT03362177. IPD Sharing: YES. Countries: 20. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer

ClinicalTrials.gov study NCT03512756. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
dryad36/100

Generation of KRAS knockout pancreatic cancer cell line PANC1

Open the record for dataset details and reuse information.

publicJan 2024View details →
dryad36/100

Data from: Downregulation of sST2, a decoy receptor for interleukin-33, enhances subcutaneous tumor growth in murine pancreatic cancer cells

Open the record for dataset details and reuse information.

publicDec 2025View details →
dryad36/100

Data from: Engineering a spatiotemporal macrophage circuit via STING phase separation to override immune suppression in pancreatic cancer

Open the record for dataset details and reuse information.

publicDec 2025View details →
dryad36/100

A mathematical model for pancreatic cancer during intraepithelial neoplasia

Open the record for dataset details and reuse information.

publicOct 2024View details →
dryad36/100

Development of human pancreatic cancer avatars as a model for dynamic immune landscape profiling and personalised therapy

Open the record for dataset details and reuse information.

publicJun 2024View details →
dryad36/100

ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1

Open the record for dataset details and reuse information.

publicApr 2025View details →
zenodo32/100

Dataset Sachindra et al: SPECT/CT imaging, biodistribution and radiation dosimetry of a 177Lu-DOTA-integrin αvβ6 cystine knot peptide in a pancreatic cancer xenograft model

<p>Numerical data for the manuscript &#39;SPECT/CT imaging, biodistribution and radiation dosimetry of a 177Lu-DOTA-integrin &alpha;v&beta;6 cystine knot peptide in a pancreatic cancer xenograft model&#39;</p>

opencc-by-4.0Dec 2020View details →
dryad32/100

Data from: A novel triptolide analog downregulates NF-kB and induces mitochondrial apoptosis pathways in human pancreatic cancer

<p>Pancreatic cancer is the seventh leading cause of cancer-related death worldwide, and despite advancements in disease management, the 5-year survival rate stands at only 12%. Triptolides have potent anti-tumor activity against different types of cancers, including pancreatic cancer, however poor solubility and toxicity limit their translation into clinical use. We synthesized a novel pro-drug of triptolide, (E)-19-[(1'-benzoyloxy-1'-phenyl)-methylidene]-Triptolide (CK21), which was formulated into an emulsion for in vitro and in vivo testing in rats and mice, and using human pancreatic cancer cell lines and patient-derived pancreatic tumor organoids. A time-course transcriptomic profiling of tumor organoids treated with CK21 in vitro was conducted to define its mechanism of action, as well as transcriptomic profiling at a single time point post-CK21 administration in vivo. Intravenous administration of emulsified CK21 resulted in the stable release of triptolide, and potent anti-proliferative effects on human pancreatic cancer cell lines and patient-derived pancreatic tumor organoids in vitro, and with minimal toxicity in vivo. Time course transcriptomic profiling of tumor organoids treated with CK21 in vitro revealed &lt;10 differentially expressed genes (DEGs) at 3 h and ~8,000 DEGs at 12 h. Overall inhibition of general RNA transcription was observed, and Ingenuity pathway analysis together with functional cellular assays confirmed inhibition of the NF-κB pathway, increased oxidative phosphorylation and mitochondrial dysfunction, leading ultimately to increased reactive oxygen species (ROS) production, reduced B-cell-lymphoma protein 2 (BCL2) expression, and mitochondrial-mediated tumor cell apoptosis. CK21 is a novel pro-drug of triptolide that exerts potent anti-proliferative effects on human pancreatic tumors by inhibiting the NF-κB pathway, leading ultimately to mitochondrial-mediated tumor cell apoptosis.</p>

opencc-zeroJan 2024View details →
dryad32/100

PP2A complex disruptor SET prompts widespread hyper-transcription of growth-essential genes in the pancreatic cancer cells

<p>Hyper-activation of the oncogenic transcription reflects the epigenetic plasticity of the cancer cells. SET was described as a nuclear factor that stimulated transcription from the chromatin template. However, the mechanisms of SET-dependent transcription are unknown. Here, we found that over-expression of SET and CDK9 induced very similar transcriptome signatures in multiple cancer cell lines. SET localized in the transcription start site (TSS)-proximal regions and supported the RNA transcription. SET specifically bound the PP2A-C subunit and induced PP2A-A subunit repulsion from the C subunit, which indicated the role of SET as a PP2A-A/C complex disruptor in the TSS-proximal regions. Through blocking PP2A activity, SET assisted CDK9 to maintain Pol II CTD phosphorylation and activated mRNA transcription. Our findings position SET as a key factor that modulates chromatin PP2A activity, promoting the oncogenic transcription in pancreatic cancer.</p>

opencc-zeroJan 2024View details →
zenodo32/100

Single Cell RNAseq Pancreatic Cancer Atlas

<p>Complete object for scRNAseq PDAC atlas.</p> <p>&nbsp;</p> <p>Please cite: Loveless IM, Kemp SB, Hartway KM, Mitchell JT, Wu Y, Zwernik SD, Salas-Escabillas DJ, Brender S, George M, Makinwa Y, Stockdale T, Gartrelle K, Reddy RG, Long DW, Wombwell A, Clark JM, Levin AM, Kwon D, Huang L, Francescone R, Vendramini-Costa DB, Stanger B, Alessio A, Waters AM, Cui Y, Fertig EJ, Kagohara LT, Theisen B, Crawford HC, Steele NG. Human pancreatic cancer single cell atlas reveals association of CXCL10+ fibroblasts and basal subtype tumor cells. Clin Cancer Res. 2024 Dec 5. doi: 10.1158/1078-0432.CCR-24-2183. Epub ahead of print. PMID: 39636224..&nbsp;</p>

opencc-by-4.0Nov 2024View details →
zenodo32/100

Coexisting mechanisms of luminogenesis in pancreatic cancer-derived organoids

<p>Source data and source code for "Coexisting mechanisms of luminogenesis in pancreatic cancer-derived organoids".</p>

opencc-by-4.0Dec 2022View details →
zenodo32/100

Lipidomic and fatty acid metabolism changes in pancreatic cancer upon ELOVL6 inhibition

<p>LC-MS data for the analysis of lipidomic and fatty acid metabolism changes in pancreatic cancer upon ELOVL6 inhibition and MYC deletion or overexpression</p>

opencc-by-4.0Feb 2024View details →
zenodo32/100

Magnetic resonance imaging in the assessment of pancreatic cancer with quantitative parameter extraction by means of dynamic contrast-enhanced magnetic resonance imaging, diffusion kurtosis imaging and intravoxel incoherent motion diffusion-weighted imaging

<p>We uploaded&nbsp;IVIM and DKI parameters values of&nbsp;included patients in the manuscript:&nbsp;Fusco, Roberta, Adele Piccirillo, Mario Sansone, Vincenza Granata, Paolo Vallone, Maria L. Barretta, Teresa Petrosino, Claudio Siani, Raimondo Di Giacomo, Maurizio Di Bonito, Gerardo Botti, and Antonella Petrillo. 2021. &quot;Radiomic and Artificial Intelligence Analysis with Textural Metrics, Morphological and Dynamic Perfusion Features Extracted by Dynamic Contrast-Enhanced Magnetic Resonance Imaging in the Classification of Breast Lesions&quot; Applied Sciences 11, no. 4: 1880. https://doi.org/10.3390/app11041880</p>

opencc-by-4.0May 2020View details →
zenodo32/100

Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence

<p>I uploaded the original images of the manuscript&nbsp;Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence accepted on Cancers journal.</p>

opencc-by-4.0Jan 2023View details →
zenodo32/100

Fig. 4 in Indole alkaloids from the leaves of Ravenia spectabilis engl. with activity against pancreatic cancer cell line

Fig. 4. Interaction of compounds 1 (A), 2 (B) and 3 (C) with DNA sequence Seq-1. All three compounds are predicted to intercalate with the DNA base pairs.

opennotspecifiedJun 2021View details →
zenodo32/100

Fig. 3 in Indole alkaloids from the leaves of Ravenia spectabilis engl. with activity against pancreatic cancer cell line

Fig. 3. Morphological changes observed in HeLa (top row) and MIA PaCa-2 (bottom row) cells after incubation with gemcitabine (A and E), compound 1 (B and F), compound 2 (C and G) and compound 3 (D and H) at their respective IC50s for 8 h.

opennotspecifiedJun 2021View details →
zenodo32/100

Fig. 2 in Panduratins Q-Y, dimeric metabolites from Boesenbergia rotunda and their antiausterity activities against the PANC-1 human pancreatic cancer cell line

Fig. 2. Connectivities (bold lines) deduced by the COSY spectrum and significant HMBC correlations (solid arrows) observed for 1–9.

opennotspecifiedMar 2021View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record